The relevant gene deregulated in del(17p) is thought to be the tumour suppressor gene TP53, as GEP has shown that myeloma samples with monoallelic 17p deletions express significantly less TP53 compared to nondeleted samples [57]. The gene discussed is TP53; the disease is plasma cell myeloma.